Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France

Cenobamate (ONTOZRY®), for the treatment of uncontrolled focal-onset seizures in adults, is now available in 5 major European countries –Germany, the UK, Italy, Spain, France – and 10 other key markets PANGYO, South Korea, Dec. 8, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global ...

2022-12-09 06:30 1896

ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit

SAN FRANCISCO, Calif., Dec. 8, 2022 /PRNewswire/ -- ReviR Therapeutics (ReviR), a biotechnology company developing small molecule therapies targeting RNA, today announced an upcoming presentation at the 5th Annual RNA Targeted Drug Discovery conference taking placeDecember 13-15, 2022 in Boston, ...

2022-12-08 23:00 2314

LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA

First Orphan Drug Designation (ODD) in the field of microbiome-based treatment for metabolic diseases SEOUL, South Korea, Dec. 8, 2022 /PRNewswire/ -- LB-P8, a novel drug being developed by LISCure Biosciences, Inc. (LISCure) as a treatment for Primary Sclerosing Cholangitis (PSC), has been desi...

2022-12-08 22:00 1825

Waterdrop CEO Peng Shen Elected as Vice Chairman of Alumni Association of Zhejiang University-The Hong Kong Polytechnic University Joint Center

BEIJING, Dec. 8, 2022 /PRNewswire/ -- On December 3, 2022, the Alumni Association of Zhejiang University-The Hong Kong Polytechnic University Joint Center held the second member representative conference, which deliberated and approved relevant work reports and charters, and elected new council m...

2022-12-08 21:30 3726

PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week

DAEJEON, South Korea, Dec. 8, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company is invited to participate in upcoming 41th Annual J.P. Morgan Healthcare ...

2022-12-08 21:00 1522

CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022

PARIS, Dec. 8, 2022 /PRNewswire/ -- On December 6, 2022, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, took part in the three-day Food Ingredients Europe 2022 (Fi Europe) held inParis, France. Fi Europe has been recognized as the industry's highest level interna...

2022-12-08 21:00 1813

CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022

Japanese Healthcare Startup Ubie, Inc. Closes Extended Series C Round at $45 million, Establishes Subsidiary in NY

TOKYO, Dec. 8, 2022 /PRNewswire/ -- Ubie, Inc., a Tokyo-based healthcare startup, announced onDecember 8 that it has closed its Series C round at $45 million by raising $19 million in an extension round. The new funding will enable Ubie to accelerate its growth and strengthen its presence in the ...

2022-12-08 16:00 2118

Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers

* QR052107B Tablet was safe and well tolerated in healthy volunteers across all tested doses, with no taste related adverse event at the anticipated therapeutic doses * Createrna initiated a clinical Phase 2 trial to study QR052107B Tablet at once-a-day (QD) dose in the treatment of refract...

2022-12-08 14:29 1756

BSR KOREA Introduces "Wizbiosolutions Inc." as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 7, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-08 00:00 2395

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

WASHINGTON, Dec. 6, 2022 /PRNewswire/ -- TIANGEN, a high-tech biological enterprise, demonstrated its revolutionary nucleic acid extraction solution at Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), fromDec 4 to...

2022-12-06 21:04 1670

Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022

Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)

* Akeso Inc. to out-license to Summit Therapeutics exclusive rights to ivonescimab (PD-1/VEGF) for the development and commercialization inthe United States, Canada, Europe, and Japan. Akeso Inc. will retain development and commercialization rights for the rest of the world includingChina. * ...

2022-12-06 21:01 2126

Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030

* Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36th new drug from the Ministry of Food and Drug Safety * Plans to enter the type 2 diabetes global market worth $71.4 billion * Provides new and broad treatment options for patients with insufficie...

2022-12-06 20:00 1326

Waterdrop Inc. Announces Third Quarter 2022 Unaudited Financial Results

BEIJING, Dec. 6, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced its unaudited financial results for the third quarter ended September 3...

2022-12-06 16:30 3840

University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

- World's First Research into Relationship between Rich-in-Biodiversity Garden Greenery and Health/Well-being - TOKYO, Dec. 6, 2022 /PRNewswire/ -- The University of Tokyo's Graduate School of Agricultural and Life Sciences (GSALS) and Sekisui House, Ltd. launched a joint research project on bio...

2022-12-06 14:00 1386

SK Biopharmaceuticals Wins Export Award for Cenobamate

SK Biopharmaceuticals receives the '$100 million Export Tower' award, becoming the first Korean pharmacompany to earn this prestige with a single innovative anti-seizure medication, cenobamate Cenobamate achieves over $100 million in exports in two years after launching in the U.S. andEurope – t...

2022-12-06 08:00 1622

Meihua International Medical Technologies Co., Ltd. Appoints New CEO, CFO and Directors

YANGZHOU, China, Dec. 5, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the appointments...

2022-12-05 22:33 1787

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

HAIKOU, China, Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced the Acquisition of Dry Eye Disease...

2022-12-05 21:00 2465

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

SHANGHAI, Dec. 5, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that after three years of preparation, the Company's MDMOOC platf...

2022-12-05 20:30 1507

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (Nasdaq: IRAA), a publicly traded special purpose acquisition company ...

2022-12-05 20:00 1372

The First IBCC Unveiled in Hainan

SHANGHAI, Dec. 5, 2022 /PRNewswire/ -- The first Integrated Bladder Cancer Center (IBCC) inHainan Province was inaugurated in Hainan General Hospital at the Hainan Provincial Urology Annual Meeting. A patient-centered facility, the IBCC serves to improve inpatient experiences as well as medical s...

2022-12-05 15:55 1233

1 ... 86 87 888990 91 92 ... 255